Consistent with Syngelaki et al. [18], Lovati et al. [32] also reported that low PAPP-A MoM levels were associated with an increased risk of requiring insulin therapy in women with GDM (p < 0.001). This evidence concerns the gene PAPPA and gestational diabetes.